Asiatic Laboratories (DHA:ASIATICLAB) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Asiatic Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Asiatic Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Asiatic Laboratories's annualized Revenue for the quarter that ended in . 20 was BDT0.00 Mil.

Asiatic Laboratories Debt-to-Revenue Historical Data

The historical data trend for Asiatic Laboratories's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Debt-to-Revenue Chart

Asiatic Laboratories Annual Data

Trend

Debt-to-Revenue

Asiatic Laboratories Semi-Annual Data

Debt-to-Revenue

Competitive Comparison of Asiatic Laboratories's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asiatic Laboratories's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's Debt-to-Revenue falls into.

Asiatic Laboratories Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Asiatic Laboratories's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

Asiatic Laboratories's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.

Asiatic Laboratories Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217

Website

http://www.asiaticpharma.com

Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines